J. V. Alstine

2006–2015

A researcher in the Science corpus: 2 papers; trusts 0 researchers and is trusted by 3 researchers here, as inferred from the citation graph.

Who trusts J. V. Alstine overall

  1. S. Jevševar

Papers from J. V. Alstine's perspective

Ordered by how strongly the researchers J. V. Alstine trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Chemistry for peptide and protein PEGylation. (Advanced Drug Delivery Reviews)
  2. Peptide and protein PEGylation: a review of problems and solutions. (Biomaterials)
  3. Engineered antibody fragments and the rise of single domains (Nature Biotechnology)
  4. The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular… (Journal of Biological Chemistry)
  5. Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. (Blood)
  6. Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease. (Gastroenterology)
  7. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. (Arthritis & Rheumatism)
  8. Antibody pharmacokinetics and pharmacodynamics. (Journal of Pharmacy and Science)
  9. Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary… (Arthritis & Rheumatism)
  10. A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease. (Gastroenterology)

Their papers